Skip to main content

Table 1 Study design and subject allocation

From: Randomized, double-blind, placebo-controlled phase I dose escalation study of Dan Qi Tong Mai tablet in healthy volunteers

CohortSingle-dose study (once)Multiple-dose study (twice daily for 14 days)
1234567891011
Increase,%Starting dose20010010067605033
Dosea90270540108018002880432057603607202160
Men34444443444
Women34444443444
Group allocation
 Active ingredients46666664666
 Placebo22222222222
 Total68888886888
  1. amg of active ingredients